Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Vaccines, Blood & Biologics

Recall: Prevnar Pneumococcal 7-valent Conjugate Vaccine, Wyeth


March 22, 2010


Prevnar Pneumococcal 7-valent Conjugate Vaccine
(Diphtheria CRM197Protein)
0.5 mL single dose pre-filled syringe (10 per package)

Prevnar Pneumococcal 7-valent Conjugate Vaccine
Lot Numbers Expiration Date
E25197 October 31, 2013
E28211 October 31, 2013
E37556 October 31, 2013
E38749 November 30, 2013


Pearl River, New York


Wyeth, now a part of Pfizer Inc., is voluntarily recalling the above four lots of Prevnar, Pneumococcal 7-valent Conjugate Vaccine, single dose pre-filled syringes. During a routine physical inspection of Prevnar pre-filled syringes, Wyeth determined that a potential exists for syringes to have been distributed with a rubber formulation in the syringe tip caps that was not approved for use with Prevnar. Wyeth performed a medical assessment and has concluded that the affected syringes present no health or safety risk to patients. Further, there would be no expected loss of potency and there is no need to revaccinate children who may have received a dose of Prevnar from an affected syringe. Customers are asked to contact the manufacturer to arrange for product return.

The information in this listing reflects CBER's best efforts to communicate information that has been reported to FDA. Its accuracy and comprehensiveness cannot be guaranteed.

Page Last Updated: 01/26/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English